Seriously, won’t the BLA give the FDA a huge black eye ? I mean I hope it does. How bad does this look if the U.K. accepts our BLA before the FDA.

I guess the question we should be asking has this happened before with a small biotech ? Anyone have any examples of a small biotech doing business outside of the U.S. first?

Seems too good to be true. I personally can’t imagine the U.K. giving the green light before the U.S.

I hope so, but this seems a bit of a stretch IMO. Politics have to be in play at this point. Maybe I’m wrong and NP has more faith in other countries.